Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
Therapeutic monoclonal antibodies and Fc-fusion proteins are successfully used in treatment of various diseases mainly including cancer, immune disease, and viral infection, which belong to the Fc-based therapeutics. In recent years, engineered Fc-derived antibody domains have also shown potential f...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018-01-01
|
| Series: | Frontiers in Immunology |
| Assuntos: | |
| Acceso en liña: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01860/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|